Avalo Therapeutics, Inc. (AVTX)
USD 9.28
(-1.07%)
USD 9.28
(-1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.92 Million | 18.05 Million | 5.39 Million | 6.69 Million | 6.75 Million | 18.32 Million |
| Cost of Revenue | 1.28 Million | 3.43 Million | 1.49 Million | 300 Thousand | 11.62 Million | 7.47 Million |
| Gross Profit | 640 Thousand | 14.61 Million | 3.9 Million | 6.39 Million | -4.87 Million | 10.84 Million |
| Operating Expenses | 640 Thousand | 52.05 Million | 86.04 Million | 53.69 Million | 24.71 Million | 29.51 Million |
| Selling, General and Administrative Expenses | 10.3 Million | 20.71 Million | 24.65 Million | 19.75 Million | 11.6 Million | 19.19 Million |
| Research and Development Expenses | 13.78 Million | 31.3 Million | 59.83 Million | 32.19 Million | 11.76 Million | 5.78 Million |
| Other Expenses | - | 38 Thousand | 1.54 Million | 1.74 Million | 1.33 Million | 13.65 Thousand |
| Cost and Expenses | 25.36 Million | 55.49 Million | 87.53 Million | 53.99 Million | 24.14 Million | 36.99 Million |
| Operating Income | -23.44 Million | -37.44 Million | -82.13 Million | -26.95 Million | -17.39 Million | -39.31 Million |
| Interest Expense | 3.41 Million | 4.17 Million | 2.39 Million | - | - | - |
| Income Tax Expense | 14 Thousand | 28 Thousand | -196 Thousand | -2.79 Million | 280 Thousand | -33.91 Thousand |
| Earnings before Tax | -31.53 Million | -41.63 Million | -84.54 Million | -67.17 Million | -15.99 Million | -40.08 Million |
| Net Income | -31.54 Million | -41.65 Million | -84.34 Million | -64.38 Million | -16.27 Million | -40.05 Million |
| Earnings Per Share Basic | -113.58 | -1062.65 | -2330.66 | -2523.77 | -819.74 | -3317.28 |
| Earnings Per Share Diluted | -113.58 | -1062.65 | -2330.66 | -2523.77 | -819.74 | -3317.28 |
| Weighted Average Shares Outstanding | 277.72 Thousand | 39.2 Thousand | 36.19 Thousand | 25.51 Thousand | 19.84 Thousand | 12.07 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 277.72 Thousand | 39.2 Thousand | 36.19 Thousand | 25.51 Thousand | 19.84 Thousand | 12.07 Thousand |
| Gross Margin | 0.33 | 0.81 | 0.72 | 0.96 | -0.72 | 0.59 |
| EBIT Margin | -14.53 | -2.07 | -14.93 | -3.76 | -2.57 | 0.35 |
| Profit Margin | -16.40 | -2.31 | -15.63 | -9.61 | -2.41 | -2.19 |
| EBITDA | -27.95 Million | -37.29 Million | -80.49 Million | -45.45 Million | -17.36 Million | -13.07 Million |
| Earnings Before Tax Margin | -12.19 | -2.07 | -15.22 | -4.02 | -2.58 | -2.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 571 Thousand | 1.92 Million | 236 Thousand | 643 Thousand |
| Cost of Revenue | 343 Thousand | -46 Thousand | -221 Thousand | 1.28 Million | 247 Thousand | 708 Thousand |
| Gross Profit | -343 Thousand | 46 Thousand | 792 Thousand | 640 Thousand | -11 Thousand | -65 Thousand |
| Operating Expenses | 9.12 Million | 5.27 Million | 4.5 Million | 24.08 Million | 3.73 Million | 7.08 Million |
| Selling, General and Administrative Expenses | 4.52 Million | 3.15 Million | 2.63 Million | - | 2.49 Million | 2.42 Million |
| Research and Development Expenses | 4.6 Million | 2.11 Million | 1.86 Million | - | 1.24 Million | 4.65 Million |
| Other Expenses | 103 Thousand | 27.37 Million | 3.9 Million | -42 Thousand | -17 Thousand | - |
| Cost and Expenses | 9.47 Million | 5.22 Million | 4.54 Million | 25.36 Million | 3.98 Million | 7.79 Million |
| Operating Income | -9.47 Million | -5.22 Million | -3.97 Million | -23.44 Million | -3.75 Million | -7.15 Million |
| Interest Expense | 1.03 Million | - | -81 Thousand | 3.41 Million | -1.55 Million | 996 Thousand |
| Income Tax Expense | 7000.00 | 7000.00 | -9000.00 | 14 Thousand | 8000.00 | 7000.00 |
| Earnings before Tax | 98.47 Million | -121.28 Million | -8.17 Million | -31.53 Million | -5.22 Million | -8.18 Million |
| Net Income | 98.46 Million | -121.29 Million | -8.16 Million | -31.54 Million | -5.22 Million | -8.19 Million |
| Earnings Per Share Basic | 4.21 | -141.14 | -10.20 | - | -26.83 | -140.73 |
| Earnings Per Share Diluted | -14.07 | -141.14 | -10.12 | - | -26.83 | -140.73 |
| Weighted Average Shares Outstanding | 1.03 Million | 859.38 Thousand | 800.92 Thousand | 277.72 Thousand | 194.85 Thousand | 58.21 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.65 Million | 859.38 Thousand | 807.38 Thousand | 277.72 Thousand | 194.85 Thousand | 58.21 Thousand |
| Gross Margin | - | - | 1.39 | 0.33 | -0.05 | -0.10 |
| EBIT Margin | - | - | -6.88 | - | -15.89 | -11.06 |
| Profit Margin | - | - | -14.30 | -16.40 | -22.15 | -12.74 |
| EBITDA | -9.43 Million | -5.19 Million | -3.92 Million | - | -3.75 Million | -7.1 Million |
| Earnings Before Tax Margin | - | - | -6.96 | -12.19 | -15.89 | -11.12 |
DE000A2NBN90
6489
WHI
PRECAM
300779
PAAS